The Antibiotic Planosporicin Coordinates Its Own Production in the Actinomycete Planomonospora Alba
The antibiotic planosporicin coordinates its own production in the actinomycete Planomonospora alba Emma J. Sherwood1 and Mervyn J. Bibb2 Department of Molecular Microbiology, John Innes Centre, Norwich, Norfolk NR4 7UH, United Kingdom Edited by E. Peter Greenberg, University of Washington, Seattle, WA, and approved May 16, 2013 (received for review March 21, 2013) Planosporicin is a ribosomally synthesized, posttranslationally mod- lantibiotics, two actinomycete compounds, NVB302 [an actagardine ified peptide lantibiotic produced by the actinomycete Planomono- derivative (9)] and NAI-107 [also known as microbisporicin (10)] spora alba. It contains one methyl-lanthionine and four lanthionine are currently in clinical development as anti-infectives, whereas bridges and inhibits cell wall biosynthesis in other Gram-positive a third, Moli1901 (also known as lancovutide or duramycin, a bacteria probably by binding to lipid II, the immediate precursor for structural analog of cinnamycin), promises to be a useful adjunct cell wall biosynthesis. Planosporicin production, which is encoded by for the treatment of cystic fibrosis (11, 12). Actinomycete RiPPs a cluster of 15 genes, is confined to stationary phase in liquid culture that have been analyzed genetically include cinnamycin (13), the and to the onset of morphological differentiation when P. alba is spore-associated proteins SapB (14) and SapT (15), michiganin grown on agar. This growth phase-dependent gene expression is (16), actagardine (17), deoxyactagardine (18), microbisporicin controlled transcriptionally by three pathway-specific regulatory pro- (19, 20), cypemycin (21), venezuelin (22), and grisemycin (23). teins: an extracytoplasmic function σ factor (PspX), its cognate anti-σ Planosporicin is another actinomycete-derived lantibiotic pro- factor (PspW), and a transcriptional activator (PspR) with a C-terminal duced by Planomonospora sp.
[Show full text]